Evidence map›Paper›PMID 39749302›Full record

ArticleIJU case reports2025

A case of choroidal metastasis from renal cell carcinoma significantly reduced by radiotherapy.

Koichiro Kanazawa, Shinnosuke Oishi, Akihiko Sakamoto, Kuniaki Tanabe, Kazutaka Sugiyama, Akihiko Matsumoto, Akari Arakawa, Hiromi Matsunaga, Takafumi Harada, Haruki Kume

Abstract read
In one paragraph

Article in IJU case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Koichiro KanazawaDepartment of Urology Yaizu City Hospital Yaizu Shizuoka Japan.ORCID https://orcid.org/0009-0001-1518-6755
Shinnosuke OishiDepartment of Urology Yaizu City Hospital Yaizu Shizuoka Japan.
Akihiko SakamotoDepartment of Urology Yaizu City Hospital Yaizu Shizuoka Japan.
Kuniaki TanabeDepartment of Urology Yaizu City Hospital Yaizu Shizuoka Japan.
Kazutaka SugiyamaDepartment of Urology Yaizu City Hospital Yaizu Shizuoka Japan.
Akihiko MatsumotoDepartment of Urology Yaizu City Hospital Yaizu Shizuoka Japan.ORCID https://orcid.org/0000-0001-6221-693X
Akari ArakawaDepartment of Ophthalmology Yaizu City Hospital Yaizu Shizuoka Japan.
Hiromi MatsunagaDepartment of Ophthalmology Yaizu City Hospital Yaizu Shizuoka Japan.
Takafumi HaradaYaizu Kogawa Ganka Yaizu Shizuoka Japan.
Haruki KumeDepartment of Urology The University of Tokyo Bunkyo City Tokyo Japan.ORCID https://orcid.org/0000-0001-9841-0857

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Choroidal metastasis from renal cell carcinoma is relatively rare and unresponsive to systemic treatment. Case presentation: A man in his eighties with left renal cell carcinoma and pulmonary metastasis developed visual impairment in the left eye during primary treatment with ipilimumab and nivolumab followed by secondary treatment with cabozantinib. Consultation with an ophthalmologist revealed choroidal metastasis, which was subsequently treated with local radiotherapy (3 Gy × 10 Fr), resulting in a significant reduction in the metastatic lesions. Conclusion: If visual impairment arises while treating renal cell carcinoma, it is essential to consider the possibility of intraocular metastasis. In terms of treatment, local therapies such as radiotherapy should be taken into consideration.

Indexed as

choroidal metastasisradiotherapyrenal cell carcinoma

Identifiers

PMID39749302
PMCPMC11693109

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.